Logo

Embecta Corp.

EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and inte… read more

Healthcare

Drug Manufacturers—Specialty & Generic

3 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$11.89

Price

+0.07%

$0.01

Market Cap

$695.574m

Small

Price/Earnings

7.3x

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

+26.8%

EBITDA Margin

+10.0%

Net Profit Margin

+29.0%

Free Cash Flow Margin

+26.8%

EBITDA Margin

+10.0%

Net Profit Margin

+29.0%

Free Cash Flow Margin
Revenue

$1.080b

-3.8%

1y CAGR

-1.4%

3y CAGR

-1.9%

5y CAGR
Earnings

$94.700m

+21.0%

1y CAGR

-12.1%

3y CAGR

-20.6%

5y CAGR
EPS

$1.62

+20.9%

1y CAGR

-12.6%

3y CAGR

-21.2%

5y CAGR
Book Value

-$650.600m

$1.091b

Assets

$1.742b

Liabilities

$1.430b

Debt
Debt to Assets

131.1%

4.8x

Debt to EBITDA
Free Cash Flow

$182.400m

+816.6%

1y CAGR

+225.2%

3y CAGR

+167.2%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases